Phosphorylated α-Synuclein in Parkinson’s DiseaseYu Wang, Jing Zhang, Catherine Pan et al.|Science Translational Medicine|2012Cited by 277
<i>GBA</i> ‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal studyKathrin Brockmann, Daniela Berg, Karin Srulijes et al.|Movement Disorders|2014Cited by 271
GBA-associated PD presents with nonmotor characteristicsKathrin Brockmann, Daniela Berg, Karin Srulijes et al.|Neurology|2011Cited by 268
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's diseaseDaniela Berg, Werner Poewe, Stefanie Behnke et al.|Movement Disorders|2012Cited by 129
The <scp>PRIPS</scp> study: screening battery for subjects at risk for <scp>P</scp>arkinson's diseaseDaniela Berg, Jana Godau, Klaus Seppi et al.|European Journal of Neurology|2012Cited by 125